author-photo

Stephen Schey

King's College London
University of Cambridge

90

Papers

3488

Citations

Citation Trend

Filter By

Papers (62) Sort By

Journal Conference Others

Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
The management of Castleman disease

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: A prospective, multi-centre longitudinal study:

2019 Palliative Medicine
Show All
- Source
- Cite
- Save
Citations (13)
Myeloma Patient Outcome Scale

2019
Show All
- Source
- Cite
- Save
Citations (0)
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

2018 Blood
Show All
- Source
- Cite
- Save
Citations (98)
RNA Sequencing of Newly Diagnosed Multiple Myeloma to Identify a Predictive Signature for Proteasome Inhibitor-Based Therapy

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Quantifying the Burden of Multiple Myeloma Across Europe

2016 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK Experience

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

2015 Haematologica
Show All
- Source
- Cite
- Save
Citations (18)
Pomalidomide - An appraisal of its clinical development and role in the treatment of relapsed/refractory multiple myeloma

2015 European Oncology and Haematology
Show All
- Source
- Cite
- Save
Citations (0)